Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:1921

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2006;113:1921.)
© 2006 American Heart Association, Inc.

Issue Highlights


*    NON–TRANSFERRIN-BOUND IRON AND RISK OF CORONARY HEART DISEASE IN POSTMENOPAUSAL WOMEN, by van der A et al.
up arrowTop
*NON-TRANSFERRIN-BOUND IRON AND...
down arrowSTEM CELL MOBILIZATION INDUCED...
down arrowMACROPHAGE METALLOELASTASE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The parallel rise in both body iron stores and vascular risk in women after menopause led to the ‘iron overload‘ theory of coronary heart disease (CHD). Epidemiological studies relating serum ferritin levels to CHD risk have yielded inconsistent results, however. In this issue of Circulation, van der A and colleagues evaluated a community-based sample of postmenopausal women to test the hypothesis that a labile iron component associated with non--transferrin-bound iron (NTBI) might be more suitable for relating to CHD risk. The investigators noted that women in the highest NTBI tertile had a statistically significant 53% lower risk of acute myocardial infarction and a nonsignificant 16% lower risk of CHD compared with those in the lowest tertile in multivariable analyses. Similar results were obtained for serum iron, transferrin saturation, and serum ferritin. These observations do not support the presence of an excess risk of CHD or myocardial infarction in postmenopausal women with relatively higher levels of NTBI or other measures of iron overload. See p 1942.


*    STEM CELL MOBILIZATION INDUCED BY SUBCUTANEOUS GRANULOCYTE-COLONY STIMULATING FACTOR TO IMPROVE CARDIAC REGENERATION AFTER ACUTE ST-ELEVATION MYOCARDIAL INFARCTION: RESULT OF THE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STEM CELLS IN MYOCARDIAL INFACTION (STEMMI) TRIAL, by Ripa et al.
up arrowTop
up arrowNON-TRANSFERRIN-BOUND IRON AND...
*STEM CELL MOBILIZATION INDUCED...
down arrowMACROPHAGE METALLOELASTASE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Percutaneous coronary revascularization procedures restore coronary flow quickly in patients with acute ST-elevation myocardial infarction, and yet there is often some degree of myocardial necrosis resulting in left ventricular dysfunction. To prevent adverse ventricular remodeling, efforts have been devoted to determining the therapeutic efficacy of bone-marrow–derived stem cells in preserving ventricular function. These cells have been isolated ex vivo and infused into the coronary artery or have been stimulated to exit the bone marrow to home to sites of myocardial injury by the administration of granulocyte-colony stimulating factor (G-CSF). Early open-label studies have demonstrated the safety and potential efficacy of G-CSF. In this issue of Circulation, Ripa et al present data from the STEM cells in Myocardial Infarction (STEMMI) Trial. This is the first report of a randomized, double-blind, placebo-controlled trial of G-CSF in patients with ST-elevation myocardial infarction and successful percutaneous revascularization. See p 1983.


*    MACROPHAGE METALLOELASTASE ACCELERATES THE PROGRESSION OF ATHEROSCLEROSIS IN TRANSGENIC RABBITS, by Liang et al.
up arrowTop
up arrowNON-TRANSFERRIN-BOUND IRON AND...
up arrowSTEM CELL MOBILIZATION INDUCED...
*MACROPHAGE METALLOELASTASE...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
In this issue of Circulation, Liang et al used a novel approach involving the generation of transgenic rabbits to study the role of the macrophage metalloelastase (matrix metalloproteinase [MMP]-12) in atherosclerosis. Their results indicate that MMP-12 causes media destruction and pseudoaneurysm formation and accelerates plaque growth in an animal model that more closely resembles atherosclerosis in humans. This transgenic rabbit model may offer new insights into the roles of MMPs in extracellular matrix remodelling and cellular migration in atherosclerotic lesion formation that may challenge some prior conclusions based on mouse models. See p 1993.

Visit http://circ.ahajournals.org:


*    Cardiology Patient Page
up arrowTop
up arrowNON-TRANSFERRIN-BOUND IRON AND...
up arrowSTEM CELL MOBILIZATION INDUCED...
up arrowMACROPHAGE METALLOELASTASE...
*Cardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Syncope. See p e715.


*    Images in Cardiovascular Medicine
up arrowTop
up arrowNON-TRANSFERRIN-BOUND IRON AND...
up arrowSTEM CELL MOBILIZATION INDUCED...
up arrowMACROPHAGE METALLOELASTASE...
up arrowCardiology Patient Page
*Images in Cardiovascular...
down arrowCorrespondence
 
Natural Tissue Engineering Inside a Ventricular Septum Defect Occluder. See p e718.


Figure 1
View larger version (42K):
[in this window]
[in a new window]
 

Transition From Left Ventricular Hypertrophy to Massive Fibrosis in the Cardiac Variant of Fabry Disease. See p e720.

External Carotid Artery--Internal Jugular Vein Fistula: A Complication of Internal Jugular Cannulation. See p e722.


*    Correspondence
up arrowTop
up arrowNON-TRANSFERRIN-BOUND IRON AND...
up arrowSTEM CELL MOBILIZATION INDUCED...
up arrowMACROPHAGE METALLOELASTASE...
up arrowCardiology Patient Page
up arrowImages in Cardiovascular...
*Correspondence
 
See p e724.


Related Articles:

Macrophage Metalloelastase Accelerates the Progression of Atherosclerosis in Transgenic Rabbits
Jingyan Liang, Enqi Liu, Ying Yu, Shuji Kitajima, Tomonari Koike, Yingji Jin, Masatoshi Morimoto, Kinta Hatakeyama, Yujiro Asada, Teruo Watanabe, Yasuyuki Sasaguri, Shigeyuki Watanabe, and Jianglin Fan
Circulation 2006 113: 1993-2001. [Abstract] [Full Text]

Syncope
Gunjan J. Shukla and Peter J. Zimetbaum
Circulation 2006 113: e715-e717. [Extract] [Full Text]

Natural Tissue Engineering Inside a Ventricular Septum Defect Occluder
Helge Möllmann, Holger M. Nef, Sawa Kostin, Woitek Skwara, Jutta Schaper, Christian W. Hamm, and Albrecht Elsässer
Circulation 2006 113: e718-e719. [Extract] [Full Text]

Transition From Left Ventricular Hypertrophy to Massive Fibrosis in the Cardiac Variant of Fabry Disease
Hiroshi Hasegawa, Hiroyuki Takano, Satoshi Shindo, Shinichi Takeda, Nobusada Funabashi, Keiichi Nakagawa, Tetsuya Toyozaki, Yoichi Kuwabara, and Issei Komuro
Circulation 2006 113: e720-e721. [Extract] [Full Text]

External Carotid Artery–Internal Jugular Vein Fistula: A Complication of Internal Jugular Cannulation
Vijay K. Sharma, Ashok W. Pereira, Benjamin K.C. Ong, Rahul Rathakrishnan, Bernard P.L. Chan, and Hock Luen Teoh
Circulation 2006 113: e722-e723. [Extract] [Full Text]

Letter Regarding Article by Ejiri et al, "Possible Role of Brain-Derived Neurotrophic Factor in the Pathogenesis of Coronary Artery Disease"
Marek Lommatzsch, J. Christian Virchow, Nobutaka Inoue, Junya Ejiri, Seiichi Kobayashi, Rio Shiraki, Kazunori Otsui, Tomoyuki Honjo, Motonori Takahashi, Toshiro Shinke, Junya Shite, Ken-ichi Hirata, Seinosuke Kawashima, Mitsuhiro Yokoyama, Hiroshi Yokozaki, Takao Mori, Yoshitaka Ohashi, Shinobu Ichikawa, Mitsuyasu Terashima, and Kojiro Awano
Circulation 2006 113: e724-e725. [Extract] [Full Text]

Non–Transferrin-Bound Iron and Risk of Coronary Heart Disease in Postmenopausal Women
Daphne L. van der A, Joannes J.M. Marx, Diederick E. Grobbee, Marjolein H. Kamphuis, Niki A. Georgiou, J. Henny van Kats-Renaud, William Breuer, Z. Ioav Cabantchik, Mark Roest, Hieronymus A.M. Voorbij, and Yvonne T. van der Schouw
Circulation 2006 113: 1942-1949. [Abstract] [Full Text]

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial
Rasmus Sejersten Ripa, Erik Jørgensen, Yongzhong Wang, Jens Jakob Thune, Jens Christian Nilsson, Lars Søndergaard, Hans Erik Johnsen, Lars Køber, Peer Grande, and Jens Kastrup
Circulation 2006 113: 1983-1992. [Abstract] [Full Text]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles